The company has drawn governments, a major chipmaker, and the Pentagon into an effort to control fragile photons and build a ...
Targeted therapies have transformed the treatment landscape for non-small cell lung cancer (NSCLC) over the past decade, particularly for patients whose tumours harbour mutations in the epidermal ...